Anti-TNFRSF8/CD30 Antibody (Brentuximab vedotin)
Catalog No.
F1042
Anti-TNFRSF8/CD30 Antibody (Brentuximab vedotin)
Featured Products
Brentuximab vedotin solution is a solution form of Brentuximab vedotin. Brentuximab vedotin (cAC10-vcMMAE) is an antibody-drug conjugate (ADC) containing an anti-CD30 antibody and the cytotoxic agent monomethyl auristatin E (MMAE).
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
145.48 kDa
Dry ice
914088-09-8
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
Adcetris, SGN-35, cAC10-vcMMAE
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P28908
Human
MMAE
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
MMAE is conjugated by sulfhydryl coupling,the DAR value of Anti-TNFRSF8/CD30 Antibody (Brentuximab vedotin) antibody is 4.0.
TNFRSF8 / CD30
Please avoid freeze-thaw cycles.